Today: 21 May 2026
ASX Top Gainers Today (12 December 2025): Rhythm Biosciences surges, while gold, uranium and “value rotation” lift Australia’s sharemarket
12 December 2025
5 mins read

ASX Top Gainers Today (12 December 2025): Rhythm Biosciences surges, while gold, uranium and “value rotation” lift Australia’s sharemarket

Sydney, 12 December 2025 — Australia’s sharemarket rallied on Friday as investors piled into resources and financials, with the S&P/ASX 200 up about 1.2% in early afternoon trade and most sectors in the green.

But the real fireworks were in individual names: a cluster of small-cap stocks posted double‑digit jumps, while large-cap miners (including gold-linked names) dominated the ASX 200’s risers list.

Below is a detailed look at today’s biggest gainers on the Australian stock market (ASX), what’s driving the moves, and the key macro and commodity themes shaping the session.


Why the ASX is rising today: miners, banks and a global “rotation” away from tech

The day’s tone was set by a familiar mix of resources strength and bank buying, supported by an offshore backdrop where materials and financials have been outperforming amid renewed caution on highly priced “AI trade” names. Reuters+2FNArena.com+2

In its live market coverage, ABC highlighted broad gains across the ASX 200’s major sectors and pointed to an overnight U.S. lead where the Dow hit records even as the Nasdaq lagged.

Commodities remained front and centre. Around early afternoon AEDT, ABC’s market snapshot showed spot gold still extremely elevated near US$4,274/oz, iron ore around US$106/t, and Brent crude near US$61.70/bbl—a mix that typically feeds straight into Australia’s resource-heavy index leadership.

Meanwhile, FNArena’s overnight report pointed to record highs in copper and silver and a continued bid for precious metals—exactly the kind of setup that tends to inflate the day’s “top risers” list with miners and commodity‑linked cyclicals. FNArena.com


Biggest ASX gainers today (all stocks): the top percentage risers

Market Index’s “Top Gainers” scan (which tracks ASX-listed shares above 1 cent) showed micro and small caps leading the market on a percentage basis during Friday’s session. Market Index

Here are today’s standout gainers (prices and moves as shown in the scan):

  • Rhythm Biosciences (ASX:RHY)+38.55% to $0.115
  • Metal Bank (ASX:MBK)+28.57% to $0.027
  • Hawk Resources (ASX:HWK)+22.73% to $0.027
  • Heavy Rare Earths (ASX:HRE)+22.22% to $0.011
  • BMC Minerals (ASX:BMC)+21.50% to $2.43
  • Pathkey.Ai (ASX:PKY)+18.75% to $0.019
  • Emperor Energy (ASX:EMP)+18.42% to $0.045
  • Energy World Corporation (ASX:EWC)+18.42% to $0.045
  • OD6 Metals (ASX:OD6)+16.67% to $0.021
  • X2M Connect (ASX:X2M)+16.67% to $0.175

Important context: Microcaps often top “percentage gainer” lists because a relatively small amount of capital can move prices sharply. These moves can also reverse quickly, especially when news flow cools or liquidity dries up.


ASX 200 top gainers today: large caps led by materials and commodity-linked names

On the large-cap side, Market Index’s ASX 200 live coverage reported that materials dominated the top-performing big names, with gold-linked and miner exposures repeatedly appearing near the top of the leaderboard.

Top ASX 200 gainers around midday (per Market Index):

  • Alcoa (AAI)+5.46% to $70.15
  • Newmont (NEM)+5.27% to $149.50
  • Genesis Minerals (GMD)+5.07% to $6.74
  • West African Resources (WAF)+4.89% to $2.90
  • Emerald Resources (EMR)+4.80% to $5.90
  • Bellevue Gold (BGL)+4.53% to $1.50
  • Perseus Mining (PRU)+4.10% to $5.47
  • Paladin Energy (PDN)+4.07% to $9.33
  • Greatland Resources (GGP)+3.96% to $8.93
  • Vault Minerals (VAU)+3.78% to $5.22

Later in the session, ABC’s live blog noted Boss Energy was the top ASX 200 mover in afternoon trade, up about 7.2%, underlining how strongly uranium-linked and resource exposures were performing on the day.


What’s driving today’s biggest gainers: key stock stories and sector themes

1) Rhythm Biosciences (RHY): surge on ColoSTAT commercialisation milestone

Today’s biggest percentage gainer, Rhythm Biosciences, jumped after an update tied to the rollout of its ColoSTAT colorectal cancer blood test.

TipRanks’ coverage of the update said the company initiated commercialisation following an updated ISO15189:2022 accreditation, with rollout through a certified Melbourne laboratory and further accreditation-related steps planned for January 2026.

Why it matters for investors: in diagnostics, the market often reacts strongly to milestones that move a product from “development narrative” into “commercial execution” — particularly if reimbursement pathways, clinician uptake, and lab capacity become the next visible catalysts.

2) Metal Bank (MBK): attention on share distribution mechanics

Metal Bank was another standout, up sharply on the day. A TipRanks company-announcement item reported that Hastings Technology Metals completed the distribution of Metal Bank shares to its shareholders following a divestment, a type of corporate action that can trigger short-term bursts of volume and price discovery.

These events can drive volatility because they abruptly change who holds the stock (and why), often producing a wave of forced or opportunistic buying/selling.

3) Heavy Rare Earths (HRE): exploration optimism meets a tight global supply narrative

Heavy Rare Earths surged as a TipRanks announcement summary pointed to promising assay results from reconnaissance sampling at Radium Hill.

Rare earths also remain a strategically sensitive theme globally. Reuters reported Vietnam approved revisions to its mineral law that restrict exports of refined rare earths while reaffirming an ore export ban, part of the ongoing reshaping of supply chains outside China.

While a single small explorer’s move will still be mostly company-specific (assays, tenements, next drill steps), broader geopolitics can amplify investor interest in the sector.

4) Gold miners dominate: Newmont, Bellevue, Genesis, West African, Emerald and more

Across the ASX 200 risers list, gold-linked names were a repeated theme.

The “why” is largely macro:

  • ABC’s market snapshot showed spot gold still around US$4,274/oz in early afternoon, keeping the bullion tailwind intact for producers and developers.
  • FNArena’s overnight report described a market environment where precious metals were rallying, with silver hitting fresh highs and metals strength feeding broader materials outperformance.

In practice, when gold is strong (or even just stubbornly high), Australian investors often bid up:

  • producers on near-term cash flow leverage, and
  • developers on improved project economics and easier funding expectations.

5) Uranium-linked names: Boss Energy and Paladin feature in ASX leaders

Uranium exposures also surfaced near the top of the ASX 200 movers. ABC specifically cited Boss Energy as the day’s leading ASX 200 mover in afternoon trade, while Market Index listed Paladin Energy among the biggest large-cap gainers around midday.

Even without a single headline catalyst, uranium stocks can move fast when the market is in a “resources risk-on” mood—especially when traders are rotating out of crowded tech positions and into commodity leverage.


The macro lens: what today’s move says about 2026 positioning

One reason today’s gainers skew so heavily toward resources is that the market is increasingly trading “2026 narratives” in advance: metals demand, infrastructure spending, energy security, and the interest-rate path.

FNArena’s overnight report framed the global setup as:

  • record highs in some industrial/precious metals,
  • ongoing debate about the pace of easing (with the Fed’s dot plot signalling fewer cuts than markets were pricing), and
  • a view that softer Australian jobs data reduced pressure for near-term RBA tightening.

Overlay that with the offshore “rotation” dynamic: Reuters reported the S&P 500 and Dow closed at record highs while investors shifted into materials and financials and away from tech after Oracle’s sharp drop. Reuters

For ASX investors, that combination tends to produce a familiar playbook:

  • buy miners (commodity beta),
  • buy banks (index heavyweights, dividend appeal),
  • sell/trim tech (valuation sensitivity when the market flinches).

What investors are watching next (and the risks behind today’s biggest gainers)

Today’s biggest gainers list mixes company-specific catalysts (diagnostics rollout, assay results, corporate actions) with macro-driven sector flows (gold/uranium/metal strength and value rotation).

A few watch points heading into the next session and beyond:

  • Follow-through vs. fade: Microcap percentage spikes can be one-day events. Look for confirming volume, further announcements, and whether the stock holds gains into the close/next open.
  • Commodity volatility: Metals have been strong, but they can reverse quickly on USD moves, rate expectations, or headline risk.
  • Rotation durability: If global markets keep rotating into value and cyclicals, ASX resources and banks can remain supported. If the market swings back to growth/AI, today’s leadership can flip just as fast.

Bottom line

Biggest ASX gainers today (12 December 2025) were led by Rhythm Biosciences (+38.55%), followed by Metal Bank (+28.57%) and Heavy Rare Earths (+22.22%), while materials-heavy large caps—including gold and uranium-linked names—dominated the ASX 200’s risers list during the session.

The broader message from Friday’s tape: in a market shaped by metals strength and a global rotation into materials and financials, Australia’s resource exposure is back in the driver’s seat—at least for now.

Stock Market Today

  • BlackBerry AtHoc Secures FedRAMP High Re-Certification Amid Share Price Debate
    May 20, 2026, 9:54 PM EDT. BlackBerry's AtHoc platform received FedRAMP High re-certification, the top U.S. government cloud security authorization, confirming its suitability for federal agencies and critical infrastructure. This supports BlackBerry's (TSX:BB) position in cybersecurity and secure communications. Despite operational strengths, BlackBerry shares trade about 30% above fair value and nearly 50% above analyst target price, signaling potential overvaluation. The stock showed a 13.5% gain over the past 30 days, indicating strong short-term momentum. Investors should monitor new U.S. federal contract awards linked to AtHoc and FedRAMP High status, which may impact revenue and earnings volatility due to large one-off items. The certification solidifies BlackBerry's federal market relevance but investor caution remains warranted amid pricing concerns.

Latest articles

SPAC ETF Up as SpaceX Heads for SPCX Ticker

SPAC ETF Up as SpaceX Heads for SPCX Ticker

21 May 2026
The SPAC and New Issue ETF, now trading as SPCK, closed up 0.64% at $22.09 on Wednesday after SpaceX filed for a $75 billion IPO under the fund’s old ticker. The fund reported $7.14 million in net assets and 41 holdings as of May 19. New listings included a $75 million IPO from Research Alliance III and filings from FutureCorp Space Acquisition 1 and JAB Acquisition I. The SEC proposed easing share issuance rules for public companies.
EnerSys Stock Flips After Earnings as Guidance Tops Trader Hopes

EnerSys Stock Flips After Earnings as Guidance Tops Trader Hopes

21 May 2026
EnerSys shares rose in after-hours trading after the company posted fourth-quarter adjusted earnings of $3.19 per share on $988 million in revenue, both above analyst estimates. The stock closed regular hours down 1.3% at $214.56, then quoted up 5.8% to $227. First-quarter profit guidance also topped forecasts. Management cited strong data center and defense demand, but noted continued weakness in motive-power and transportation.
Silexion Soars After Cancer Study, Liquidity and Nasdaq Issues Linger for SLXN

Silexion Soars After Cancer Study, Liquidity and Nasdaq Issues Linger for SLXN

21 May 2026
Silexion Therapeutics shares surged 97% to $0.5298 on Wednesday with over 325 million shares traded, then fell 9.5% after hours. The move followed news that Israel approved a Phase 2/3 trial of its lead pancreatic cancer drug, SIL204. Silexion reported a Q1 net loss of $2.7 million and $2.4 million in cash. The company plans a 1-for-10 reverse share split by early June.
Costco Stock After Q1 2026 Earnings: How COST Is Trading After the Bell on December 11, 2025 – and What to Watch Before the Market Opens on December 12
Previous Story

Costco Stock After Q1 2026 Earnings: How COST Is Trading After the Bell on December 11, 2025 – and What to Watch Before the Market Opens on December 12

Best Stocks to Buy Now in Singapore: Top SGX Picks, Fresh Catalysts, and 2026 Outlook (Updated 12 Dec 2025)
Next Story

Best Stocks to Buy Now in Singapore: Top SGX Picks, Fresh Catalysts, and 2026 Outlook (Updated 12 Dec 2025)

Go toTop